Author:
Darbar Soumendra,Saha Srimoyee,Pramanik Kausikisankar,Chattopadhyay Atiskumar
Abstract
Background: Tramadol hydrochloride/paracetamol (THP) a fixed dose combination (FDC) is widely spread analgesic used to treat moderate to moderately severe pain. Over dose or chronic use of this fixed dose combination produce serious adverse effects. An acute Tramadol hydrochloride/paracetamol (THP) overdose can lead to a fatal liver damage.
Objectives: There is a worldwide need to develop a safe and symptomatic medication which controls the different medical complications.
Materials and Methods: Healthy adult swiss albino mice were assigned to four groups of six mice each according to their weights. Group-I serve as control, Group-II received Multi herbal formulation (AKSS16 LIV01) 400 mg/kg/day, Group-III received Tramadol hydrochloride/paracetamol (THP) 1.68 g / 300ml water and Group-IV received THP along with AKSS16-LIV01 (400 mg/kg). Blood samples were collected from the retro orbital plexus of each animal to determine various blood parameters and liver transaminase. Results: Administration of THP showed decline body weight, food consumption and water intake in mice whereas treatment with Multi herbal formulation (AKSS16-LIV01) normalized the same as compared with untreated animals. Treatment with THP (Group-III) decline the packed cell volume (PCV), haempglobin (Hb), means cell volume (MCV), means cell hemoglobin (MCH) and greater the white blood cell (WBC) compared with control. Pre-treatment with AKSS16-LIV01 significantly (p<0.001) increased the PCV, Hb, MCH, MCH and decreased WBC count in experimental animals. On the other hand elevated liver transaminase enzymes i.e. AST and ALP by THP was restored with administration of Multi herbal formulation (AKSS16-LIV01).
Conclusion: Chronic administration of THP indicated adverse effects on haematologic parameters upon experimental animals. Simultaneous administration with newly developed multi herbal formulation (AKSS16-LIV01) was ameliorate these adverse effects and may be potent drug In the future which controls the blood related medical complications against the toxicants.
Keywords: Tramadol hydrochloride/paracetamol; Fixed dose combination; Multi herbal formulation; Hematologic parameters; Liver transaminase; Swiss albino mice
Publisher
Society of Pharmaceutical Tecnocrats
Reference21 articles.
1. 1. Food U, Administration D: Fda Warns About Several Safety Issues With Opioid Pain Medicines; Requires Label Changes. Fda Drug Safety Communication. In.; 2016.
2. 2. Mitrašinović-Brulić M, Kulovac A, Suljević D: Chronic Effects Of Tramadol Hydrochloride/Paracetamol Oral Administration On Haematological Parameters And Glucose Level In Wistar Rats.
3. Leppert W: Tramadol As An Analgesic For Mild To Moderate Cancer Pain;3;Pharmacological Reports,2009
4. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül Ö, Kozak O, Kurt E, Aypar U: Spinal 5-Ht7 Receptors Play An Important Role In The Antinociceptive And Antihyperalgesic Effects Of Tramadol And Its Metabolite, O-Desmethyltramadol, Via Activation Of Descending Serotonergic Pathways;4;Anesthesiology,2010
5. Kaneko K, Umehara M, Homan T, Okamoto K, Oka M, Oyama T: The Analgesic Effect Of Tramadol In Animal Models Of Neuropathic Pain And Fibromyalgia;5;Neuroscience Letters,2014